Cantitate/Preț
Produs

Regenerative and Cell Therapy: Clinical Advances: Ernst Schering Foundation Symposium Proceedings, cartea 11

Editat de A. Keating, K. Dicke, N. Gorin, R. Weber, H. Graf
en Limba Engleză Hardback – 8 oct 2004
This book gives an updated review of the state of the art in regenerative cell therapy in the fields of cardiology, hematology, pediatrics, neurology, orthopedics and infectious diseases. The book emphasizes clinical advances as proof of concept in cell therapy based on the revolutionizing observation that regeneration can occur throughout the body even in highly differentiated organs like the heart and the neuronal system. It provides examples of breakthroughs in the clinical implementation of adult stem cell therapy.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 71006 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 23 noi 2014 71006 lei  6-8 săpt.
Hardback (1) 71737 lei  6-8 săpt.
  Springer Berlin, Heidelberg – 8 oct 2004 71737 lei  6-8 săpt.

Din seria Ernst Schering Foundation Symposium Proceedings

Preț: 71737 lei

Preț vechi: 75513 lei
-5% Nou

Puncte Express: 1076

Preț estimativ în valută:
13730 14278$ 11489£

Carte tipărită la comandă

Livrare economică 14-28 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783540220930
ISBN-10: 3540220933
Pagini: 196
Ilustrații: XII, 180 p.
Dimensiuni: 140 x 216 x 16 mm
Greutate: 0.46 kg
Ediția:2005
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seriile Ernst Schering Foundation Symposium Proceedings, Schering Foundation Symposium Proceedings Supplements

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Cuprins

Problems and Hopes with Cell Therapy: The Case of Muscular Dystrophy.- Cardiac Myoblasts.- Tissue Engineering, Stem Cells, and Cloning: Current Concepts and Future Trends.- Bone Marrow Cell Therapy for Genetic Disorders of Bone.- Immune-Based Cell Therapy for Acute and Chronic Neurodegeneratlve Disorders.- Mesenchymal Stem Cells for the Treatment of Hematological Malignancies.- Perspectives in Transfusion Medicine for the Ex Vivo Control of Hematopoiesis.- T-Cell Therapies for EBV-Associated Malignancies.- Peptide Vaccination of Myeloid Leukemia.- Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning.